Related Experiment Video
Updated: Sep 16, 2025

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
Hemolytic Uremic Syndrome Following Holmium Laser Enucleation of the Prostate: A Case Report
Wojciech Krajewski1, Lukasz Nowak1, Patryk Patrzałek2
1University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, Wroclaw, POL.
Abstract:
Holmium laser enucleation of the prostate (HoLEP) is a widely used surgical treatment for benign prostatic hyperplasia (BPH), and it is associated with a low incidence of severe complications. We report a rare case of hemolytic uremic syndrome (HUS) following HoLEP in a 71-year-old male. Shortly after the surgery, the patient developed altered consciousness, jaundice, and multiorgan failure, necessitating intensive care and renal replacement therapy. HUS was identified as the underlying cause. After a month-long hospitalization, the patient showed progressive renal recovery. This report underscores the importance of early recognition, multidisciplinary management, and close follow-up in achieving favorable outcomes in rare post-HoLEP complications.

